Optimizing Outcomes Across the Pharma Value Chain Network

Previously Aired on October 19th, 2021

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

The ability of bio-pharmaceutical manufacturers to deliver quality drug products during challenging market conditions is critical for ensuring sustainability over the long run. The COVID-19 pandemic underscored the need to transform the traditional bio-pharmaceutical supply chain to have greater agility and resiliency during market swings and periods of volatility.

Please join Pharmaceutical Outsourcing Editor-in-Chief Mike Auerbach for a lively discussion with industry experts Daniel Matlis, President and Founder, Axendia, and David Leitham, SVP and GM, Pharmaceutical Business Unit, AspenTech, as they address these hot-button topics:

  • What are the challenges that have limited the pharmaceutical industry from moving forward with digitalization?
  • What is digital maturity and why is it a requirement for pharmaceutical manufacturing?
  • Where should pharmaceutical companies begin their digitalization journey?
There will be a Q&A session following the event. We encourage you to join the conversation by submitting questions when registering.

Who should attend:

  • Executives, VPs and Directors in pharmaceutical and biopharmaceutical manufacturing, operations, quality and supply chain at pharma companies, contract manufacturing and contract development and manufacturing organizations 

Presenters

Presenter
David Leitham
(Presenter)
GM, SVP Pharmaceuticals,
Aspen Technology, Inc.
View Biography
Presenter
Daniel R. Matlis
(Presenter)
President and Founder,
Axendia
View Biography
Presenter
Michael Auerbach
(Moderator) Editor-in-Chief
Pharmaceutical Outsourcing